Pmv Pharmaceuticals, Inc
Clinical trials sponsored by Pmv Pharmaceuticals, Inc, explained in plain language.
-
First-of-its-Kind pill targets Cancer's 'Guardian Gene' mutation
Disease control Recruiting nowThis study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new cancer Pill's safety with common drugs
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a new oral cancer drug, rezatapopt, interacts with four common medications (metformin, rosuvastatin, repaglinide, and midazolam). It will enroll about 14 adults with advanced solid tumors that have a specific genetic mutation called T…
Phase: PHASE1 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC